- Record: found
- Abstract: not found
- Article: not found
PIK3CA status in circulating tumor DNA (ctDNA) predicts efficacy of buparlisib (BUP) plus fulvestrant (FULV) in postmenopausal women with endocrine-resistant HR+/HER2- advanced breast cancer (BC): First results from the randomized, phase III BELLE-2 trial
J. BASELGA, SA Im, H. IWATA, M Clemons, Y ITO, A Awada, S Chia, A Jagiello-Gruzfeld, B Pistilli, LM Tseng, S. Hurvitz, N Masuda, J. CORTÉS
2016
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Comments
Comment on this article
Similar content516
- Studies of the oxovanadium-organophosphonate system: Formation of pyrodiphosphonate and pyrophosphophosphonate units through metal-mediated ligand condensations. The crystal and molecular structures of (Ph4P)2[VO{RP(O)2OP(O)2 R}2] (R=Me, Ph) and (Ph4P)2(n-Bu4N)[(VO)6V{t-BuP(O)2OPO3}6]Authors: Jos� Salta, Jon. Zubieta